NWAJX
Price
$20.26
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
VFWPX
Price
$123.05
Change
-$0.07 (-0.06%)
Updated
Nov 14 closing price
Ad is loading...

NWAJX vs VFWPX

Header iconNWAJX vs VFWPX Comparison
Open Charts NWAJX vs VFWPXBanner chart's image
Nationwide Janus Henderson Ovrs Eagle
Price$20.26
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard FTSE All-Wld ex-US Idx Ins Plus
Price$123.05
Change-$0.07 (-0.06%)
VolumeN/A
CapitalizationN/A
NWAJX vs VFWPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NWAJX vs. VFWPX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NWAJX is a Buy and VFWPX is a Buy.

FUNDAMENTALS
Fundamentals
VFWPX has more cash in the bank: 56.7B vs. NWAJX (46.8M). VFWPX (3.36) and NWAJX (3.30) have matching dividends . NWAJX was incepted earlier than VFWPX: NWAJX (5 years) vs VFWPX (14 years). NWAJX is a more actively managed with annual turnover of: 40.07 vs. VFWPX (4.00). NWAJX has a lower initial minimum investment than VFWPX: NWAJX (50000) vs VFWPX (100000000). NWAJX annual gain was more profitable for investors over the last year : 12.40 vs. VFWPX (11.15). VFWPX return over 5 years is better than : 16.59 vs. NWAJX (13.60).
NWAJXVFWPXNWAJX / VFWPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years14 years-
Gain YTD6.1515.362115%
Front LoadN/AN/A-
Min. Initial Investment500001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets46.8M56.7B0%
Annual Yield % from dividends3.303.3698%
Returns for 1 year12.4011.15111%
Returns for 3 years-32.77-4.76689%
Returns for 5 years13.6016.5982%
Returns for 10 yearsN/A31.03-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIN80.52-1.59
-1.94%
Albany International Corp
EYPT10.49-0.27
-2.51%
EyePoint Pharmaceuticals
RMAX11.23-0.45
-3.85%
Re/Max Holdings
CRL196.90-9.64
-4.67%
Charles River Laboratories International
LMFA2.65-0.29
-9.86%
LM Funding America